Resonance Specialties Limited (BOM:524218)

India · Delayed Price · Currency is INR

143.80

+4.90 (3.53%)

At close: Jul 31, 2026

22.96% (1Y)

Market Cap	1.66B +23.0%
Revenue (ttm)	902.48M +16.0%
Net Income	103.96M +58.3%
EPS	9.01 +58.3%
Shares Out	11.54M
PE Ratio	15.97
Forward PE	n/a
Dividend	1.00 (0.70%)
Ex-Dividend Date	Jul 28, 2026

Volume	5,668
Open	140.50
Previous Close	138.90
Day's Range	140.50 - 144.50
52-Week Range	77.00 - 150.65
Beta	0.35
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 4, 2026

About Resonance Specialties

Resonance Specialties Limited engages in the manufacture and marketing of specialty chemicals in India and internationally. It offers pyridine, a chemical used in manufacturing agrochemicals, pharmaceuticals and bulk drugs, dyes, rubber chemicals, etc.; cyanopyridines that are applied in manufacturing of niacinamide; and picolines, including alpha, beta, and gamma picolines used in manufacturing vinyl latex rubber, vitamin B3, and anti-tuberculosis drugs. The company also provides nutritional drug products, such as zinc and chromium picolinate,... [Read more]

Industry Medicinal Chemicals and Botanical Products

Founded 1989

Employees 74

Stock Exchange Bombay Stock Exchange

Ticker Symbol 524218

Full Company Profile

Financial Performance

In fiscal year 2026, Resonance Specialties's revenue was 902.48 million, an increase of 15.99% compared to the previous year's 778.07 million. Earnings were 103.96 million, an increase of 58.32%.

Financial Statements